What is the recommended gabapentin dosing regimen for seizure control in adults and children, including adjustments for renal impairment?

Gabapentin Dosing for Seizures

For adults and children ≥12 years with partial-onset seizures, initiate gabapentin at 300 mg three times daily and titrate to a maintenance dose of 900-1800 mg/day in three divided doses, with a maximum of 3600 mg/day; for children 3-11 years, start at 10-15 mg/kg/day divided three times daily and titrate over 3 days to a maintenance dose of 25-35 mg/kg/day (ages 5-11) or 40 mg/kg/day (ages 3-4), with mandatory dose reduction based on creatinine clearance in all patients with renal impairment. 1

Adult Dosing (≥12 years)

Initial Dosing and Titration

• Start with 300 mg three times daily on Day 1 1
• The maximum time between doses must not exceed 12 hours 1
• Titrate to maintenance dose of 300-600 mg three times daily (900-1800 mg/day total) 1
• Dosages up to 2400 mg/day are well tolerated in long-term studies, and doses of 3600 mg/day have been administered safely for shorter durations 1

Evidence for Higher Dosing

• Clinical studies demonstrate efficacy across 1800-3600 mg/day, though additional benefit above 1800 mg/day was not clearly demonstrated in controlled trials 1
• However, open-label studies suggest improved seizure control at maintenance dosages ≥3600 mg/day without increased adverse reactions 2
• In a large multicenter study of 2016 patients, 76% achieved ≥50% seizure reduction and 46.4% became seizure-free with doses up to 3600 mg/day 3

Optimal Titration Strategy

• Gabapentin may be initiated at 900 mg/day and rapidly titrated to ≥3600 mg/day in most adult patients 2
• Side effects typically occur at onset of dosing and are often transient 2
• Allow adequate time for therapeutic assessment—optimal seizure control may require months to achieve 2

Pediatric Dosing (Ages 3-11 years)

Weight-Based Dosing

• Starting dose: 10-15 mg/kg/day divided three times daily 1
• Titrate upward over approximately 3 days to maintenance dose 1
• Ages 3-4 years: Maintenance dose of 40 mg/kg/day in three divided doses 1
• Ages 5-11 years: Maintenance dose of 25-35 mg/kg/day in three divided doses 1
• Dosages up to 50 mg/kg/day have been well tolerated in long-term studies 1
• Maximum time between doses must not exceed 12 hours 1

Clinical Evidence in Children

• In open-label studies, children with refractory partial epilepsy received 10-50 mg/kg/day (mean 26.7 mg/kg/day), with 34.4% achieving >50% seizure reduction 4
• Children may be treated with 23-78 mg/kg/day based on controlled and open trials 2

Formulation Flexibility

• Gabapentin may be administered as oral solution, capsule, or tablet, or combinations of these formulations 1

Critical Renal Dose Adjustments

Mandatory Assessment

• Calculate creatinine clearance using the Cockcroft-Gault equation before initiating therapy in all patients 1
• Elderly patients are more likely to have decreased renal function and require dose adjustment based on creatinine clearance 1

Dose Reduction by Creatinine Clearance (Adults ≥12 years)

CrCl ≥60 mL/min:

• Total daily dose: 900-3600 mg/day
• Dosing: 300-1200 mg three times daily 1

CrCl 30-59 mL/min:

• Total daily dose: 400-1400 mg/day
• Dosing: 200-700 mg twice daily 1

CrCl 15-29 mL/min:

• Total daily dose: 200-700 mg/day
• Dosing: 100-700 mg once daily 1

CrCl <15 mL/min:

• Total daily dose: 100-300 mg/day
• Dosing: 100-300 mg once daily
• Reduce daily dose in proportion to creatinine clearance (e.g., CrCl 7.5 mL/min receives half the dose for CrCl 15 mL/min) 1

Hemodialysis patients:

• Receive maintenance doses based on creatinine clearance estimates above
• Administer supplemental post-hemodialysis dose of 125-350 mg after each 4 hours of hemodialysis 1

Pediatric Renal Impairment

• Use of gabapentin in patients <12 years with compromised renal function has not been studied 1
• A 2025 PBPK modeling study suggests that in pediatric RI patients under 12 years, AUC increases 2.09-fold (mild RI), 3.30-fold (moderate RI), and 31.67-fold (severe RI) compared to healthy children 5
• Recommended dosing frequency adjustments: twice daily for mild RI, once daily for moderate RI, and every other day with 50% dose reduction for severe RI 5

Administration and Discontinuation

Administration Guidelines

• Administer orally with or without food 1
• If dividing scored 600 mg or 800 mg tablets, take unused half-tablet as next dose 1
• Discard half-tablets not used within 28 days 1

Discontinuation Protocol

• If reducing, discontinuing, or substituting gabapentin, taper gradually over minimum of 1 week (longer period may be needed at prescriber's discretion) 1

Adverse Effects Profile

Common Side Effects

• Most common: dizziness, fatigue, and headache 6
• Behavioral effects (hyperactivity, agitated behavior) occur rarely, usually in children with pre-existing behavioral disturbances 6
• No significant idiosyncratic reactions have been reported 6

Pediatric-Specific Considerations

• Major reported side effects in children are behavioral: hyperactivity, irritability, and agitation, occurring primarily in patients with baseline mental retardation and attention deficit 4

Critical Pitfalls to Avoid

• Never assume lack of efficacy without adequate therapeutic trial—optimal seizure control may take months 2
• Do not fail to assess renal function before initiating therapy, especially in elderly patients 1
• Avoid abrupt discontinuation—always taper gradually over at least 1 week 1
• Do not use standard dosing in patients with any degree of renal impairment without calculating creatinine clearance and adjusting dose accordingly 1
• Gabapentin has no protein binding, is not metabolized, and is excreted unchanged through the kidneys, making renal function assessment non-negotiable 6